# FDA 483 - Tomasz M. Ziedalski, M.D. - July 09, 2026

Source: https://www.keypedia.com/records/483/tomasz-m-ziedalski-md/bc7bc6f7-4e70-487b-8054-504722dcfefc

> FDA 483 for Tomasz M. Ziedalski, M.D. on July 09, 2026. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Tomasz M. Ziedalski, M.D.
- Inspection Date: 2026-07-09
- Product Type: other
- Office Name: Seattle District Office
- Summary: An FDA inspection of Tomasz M. Ziedalski, M.D. in Everett, WA, a clinical investigator, revealed two significant issues. The firm failed to obtain informed consent from a human subject prior to conducting study-related tests. Additionally, the investigator did not document clinically significant laboratory values as adverse events in accordance with the investigational plan.

## Related Officers

- [Logan M. Jones](https://www.keypedia.com/people/logan-m-jones/286ab813-461a-4bfc-a732-bcd4f0d6e596)

Company: https://www.keypedia.com/companies/tomasz-m-ziedalski-md/f81bfc7e-3ab7-41fa-8885-9e775d48598f

Office: https://www.keypedia.com/offices/seattle-district-office/9305837f-0738-4075-b444-a55e7a2b8913